Clinical trial

Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy

NCT06459193

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-06-23

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2024-06-23Date precision: day

Registry last updated2025-03-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Peripheral Neuropathy Due to Chemotherapyunresolved

Interventions

TrimetazidineDRUG

PlaceboDRUG

Sponsors & collaborators

Minia Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06459193 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.